Search Results for the EPA National Library Catalog

Items Found: 50

Showing: Items 1 - 50

Your Search: (SUBJECT=Antineoplastic agents)


Select Item Title Year Published
  1 Alleviation of Lake Pollution by Utilization of Aquatic Plants for Nutritional, Medicinal or Industrial Purposes. 1973
  2 Anticancer drug research 1987
  3 Antineoplastic agents 1984
  4 Antitumor natural products basic and clinical research / 1989
  5 Aquatic Plants from Minnesota. Part II. Toxicity, Anti-Neoplastic, and Coagulant Effects. 1972
  6 Basis for cancer management 1996
  7 Bioassay of 3,3'-iminobis-1-propanol dimethanesulfonate (ester) hydrochloride (IPD) for possible carcinogenicity. 1978
  8 Bioassay of 5-azacytidine for possible carcinogenicity. 1978
  9 Bioassay of beta-2'-deoxy-6-thioguanosine monohydrate for possible carcinogenicity. 1978
  10 Bioassay of estradiol mustard for possible carcinogenicity. 1978
  11 Bioassay of ICRF-159 for possible carcinogenicity. 1978
  12 Bioassay of isophosphamide for possible carcinogenicity. 1977
  13 Bioassay of phenesterin for possible carcinogenicity. 1978
  14 Bioassay of thio-TEPA for possible carcinogenicity. 1978
  15 Biological response modifiers 1983
  16 Biological response modifiers, leukaemias and lymphomas 1987
  17 Characterization of Air Particulate Material for Polycyclic Aromatic Compounds. 1983
  18 Chemotherapy 1977
  19 Chlorinated Compounds Found in Waste-Treatment Effluents and Their Capacity to Bioaccumulate. 1976
  20 Computer-Automated Structure Evaluation of Antileukemic 9-Anilinoacridines. 1987
  21 Concept of Activity Profiles of Antimutagens. 1989
  22 Consideration of Pharmacokinetics and Temporal Sensitivity for Hydroxyurea in Relation to Teratogenic Potential. 1991
  23 Diesel Emissions Symposium proceedings / 1982
  24 DNA Adducts of the Antitumor Agent Diaziquone. 1992
  25 Effect of Chemotherapy on the In vivo Frequency of Glycophorin A 'Null' Variant Erythrocytes (Revised). 1990
  26 Effect of Dibutylnitrosamine and Saccharin on Glutamyl Transpeptidase-Positive Foci and Liver Cancer. 1983
  27 Efficient Multiple-Exposure Analysis of the Toxicity of Crisnatol: A DNA Intercalator in Phase 2 Clinical Trials. 1992
  28 Evaluation of the potential carcinogenicity of lead and lead compounds : in support of reportable quantity adjustments pursuant to CERCLA section 102. 1989
  29 Evaluation of the potential carcinogenicity of lead and lead compounds: in support of reportable quantity adjustments pursuant to CERCLA) {microform} / 1989
  30 Experimental evaluation of antitumor drugs in the USA and USSR and clinical correlations 1981
  31 Identification of selected Federal activities directed to chemicals of near-term concern : benzene, bis(chloromethyl) ether, cadmium, hydrogen sulfide, mercury, platinum, polynuclear aromatic hydrocarbons, trichloroethylene, tris(2, 3-dibromopropyl), phosphate / 1976
  32 Induction, Accumulation, and Persistence of Sister Chromatid Exchanges in Women with Breast Cancer Receiving Cyclophosphamide, Adriamycin, and 5-Fluorouracil Chemotherapy. 1990
  33 Inhibition of carcinogenesis 1971
  34 Inhibition of tumor induction and development 1981
  35 Laboratory decontamination and destruction of carcinogens in laboratory wastes : some antineoplastic agents / 1985
  36 Limitations of the Fluorescent Probe Viability Assay. 1989
  37 Manganese Chloride Enhances Murine Cell-Mediated Cytotoxicity: Effects on Natural Killer Cells. 1984
  38 Modifiers of chemical carcinogenesis an approach to the biochemical mechanism and cancer prevention / 1980
  39 Molecular and cellular biology of multidrug resistance in tumor cells 1991
  40 Molecular cancer therapeutics. 2001
  41 Monetizing the Pharmacological Benefits of Plants. 1991
  42 Persistence of SCE (Sister Chromatid Exchange)-Inducing Lesions in Lymphocytes of Mice Exposed to Diaziquone (Journal Version). 1988
  43 Principles of chemoprevention 1996
  44 Prolonged Survival of Female AKR Mice Fed Diets Supplemented with Methionine and Choline. 1990
  45 Some antineoplastic and immunosuppressive agents. 1981
  46 Some antiviral and antineoplastic drugs, and other pharmaceutical agents. 2000
  47 Structure-activity relationships of anti-tumour agents 1983
  48 Theoretical foundations of cancer chemotherapy introduced by computer models 1992
  49 Utility of the Murine Erythroleukemic Cell (MELC) in Assessing Mechanisms of Action of DNA-Active Developmental Toxicants: Application to 5-Fluorouracil. 1993
  50 Working group on molecular mechanisms of carcinogenic and antitumor activity, October 21-25, 1986 1987

Save, Print or Email Selected Records